Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

The challenge of tracking asymptomatic Mpox

20

Jan 2026

The challenge of tracking asymptomatic Mpox

The mpox virus appears to be circulating silently in parts of Nigeria, in many cases without the symptoms typically associated with the disease, according to new research led by scientists from the University of Cambridge and partners in Nigeria. The findings may have implications for controlling the spread of the disease.

How "old RNA" reshapes sperm metabolism

20

Jan 2026

How "old RNA" reshapes sperm metabolism

Increasing paternal age has been linked to elevated health risks for the next generation, including higher risks of obesity and stillbirth. But what drives this increased risk remains unknown.

Tracing the ancient lineage of canine heartworm disease

20

Jan 2026

Tracing the ancient lineage of canine heartworm disease

Research led by the University of Sydney is reshaping scientific understanding of one of the world's most widespread canine parasites, suggesting heartworm disease has a far deeper and more complex evolutionary history than previously believed – including a possible ancient origin of Australian heartworms linked to dingoes.

Orchestrating a global response to the mosquito threat

20

Jan 2026

Orchestrating a global response to the mosquito threat

Mosquitoes are more than just a summer nuisance; they pose a significant global health challenge, killing over 700,000 people every year. Mosquito-borne diseases such as dengue, Zika, and chikungunya were once considered distant threats, but climate change and rapid urbanisation are enabling mosquitoes to spread to new areas, including parts of Europe.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.